Business Description
Foresee Pharmaceuticals Co Ltd
ISIN : TW0006576002
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.92 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | -0.25 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 7.89 | |||||
Beneish M-Score | 1.14 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12 | |||||
3-Year EBITDA Growth Rate | -19.3 | |||||
3-Year EPS without NRI Growth Rate | -17.8 | |||||
3-Year FCF Growth Rate | -2.3 | |||||
3-Year Book Growth Rate | -16 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.95 | |||||
9-Day RSI | 38.63 | |||||
14-Day RSI | 41.2 | |||||
6-1 Month Momentum % | 16.89 | |||||
12-1 Month Momentum % | 7.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.38 | |||||
Quick Ratio | 3.11 | |||||
Cash Ratio | 2.87 | |||||
Days Inventory | 655.79 | |||||
Days Sales Outstanding | 86.21 | |||||
Days Payable | 96.95 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.7 | |||||
Shareholder Yield % | -11.27 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.44 | |||||
Operating Margin % | -516.63 | |||||
Net Margin % | -531.33 | |||||
FCF Margin % | -478.8 | |||||
ROE % | -82.63 | |||||
ROA % | -59.72 | |||||
ROIC % | -209.66 | |||||
ROC (Joel Greenblatt) % | -424.32 | |||||
ROCE % | -66.13 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 62.65 | |||||
PB Ratio | 10.37 | |||||
Price-to-Tangible-Book | 11.56 | |||||
EV-to-EBIT | -11.97 | |||||
EV-to-EBITDA | -12.92 | |||||
EV-to-Revenue | 60.47 | |||||
EV-to-FCF | -12.41 | |||||
Price-to-Net-Current-Asset-Value | 13.26 | |||||
Price-to-Net-Cash | 17.58 | |||||
Earnings Yield (Greenblatt) % | -8.35 | |||||
FCF Yield % | -7.23 |